标题
Estimands for recurrent event endpoints in the presence of a terminal event
作者
关键词
-
出版物
Statistics in Biopharmaceutical Research
Volume -, Issue -, Pages 1-29
出版商
Informa UK Limited
发表日期
2021-03-01
DOI
10.1080/19466315.2021.1895883
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A causal framework for classical statistical estimands in failure‐time settings with competing events
- (2020) Jessica G. Young et al. STATISTICS IN MEDICINE
- A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks
- (2020) Yanxun Xu et al. BIOSTATISTICS
- The win ratio: On interpretation and handling of ties
- (2019) Gaohong Dong et al. Statistics in Biopharmaceutical Research
- Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice
- (2019) C. H. Mallinckrodt et al. Therapeutic Innovation & Regulatory Science
- A constructive critique of the draft ICH E9 Addendum
- (2019) Daniel O Scharfstein Clinical Trials
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence
- (2019) Baldur P. Magnusson et al. STATISTICS IN MEDICINE
- Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
- (2019) Frank Pétavy et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Causal Inference and Estimands in Clinical Trials
- (2019) Ilya Lipkovich et al. Statistics in Biopharmaceutical Research
- Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study
- (2018) Brian Claggett et al. STATISTICS IN MEDICINE
- Limitations of hazard ratios in clinical trials
- (2018) Mats J Stensrud et al. EUROPEAN HEART JOURNAL
- Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
- (2017) Naoki Sato et al. JOURNAL OF CARDIAC FAILURE
- Estimands and Their Role in Clinical Trials
- (2017) Mouna Akacha et al. Statistics in Biopharmaceutical Research
- Inference in randomized trials with death and missingness
- (2016) Chenguang Wang et al. BIOMETRICS
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
- (2016) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components
- (2016) Gaohong Dong et al. PHARMACEUTICAL STATISTICS
- Estimands in clinical trials - broadening the perspective
- (2016) Mouna Akacha et al. STATISTICS IN MEDICINE
- Semiparametric regression for the weighted composite endpoint of recurrent and terminal events
- (2015) Lu Mao et al. BIOSTATISTICS
- Does Cox analysis of a randomized survival study yield a causal treatment effect?
- (2015) Odd O. Aalen et al. LIFETIME DATA ANALYSIS
- A taxonomy of estimands for regulatory clinical trials with discontinuations
- (2015) Thomas Permutt STATISTICS IN MEDICINE
- Choosing Appropriate Estimands in Clinical Trials
- (2015) Ann-Kristin Leuchs et al. Therapeutic Innovation & Regulatory Science
- Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints
- (2014) B. Claggett et al. BIOSTATISTICS
- Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
- (2014) Jennifer K. Rogers et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
- (2014) Jennifer K. Rogers et al. JACC-Heart Failure
- Moving beyond our comfort zone
- (2013) Brian Claggett et al. EUROPEAN HEART JOURNAL
- Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia
- (2012) Sumeet Subherwal et al. AMERICAN HEART JOURNAL
- Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?
- (2012) S. D. Anker et al. EUROPEAN HEART JOURNAL
- A Refreshing Account of Principal Stratification
- (2012) Fabrizia Mealli et al.
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Composite outcomes: weighting component events according to severity assisted interpretation but reduced statistical power
- (2010) Uchechukwu K.A. Sampson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- A Global Ranking Approach to End Points in Trials of Mechanical Circulatory Support Devices
- (2008) G. Michael Felker et al. JOURNAL OF CARDIAC FAILURE
- Randomization Does Not Justify Logistic Regression
- (2008) David A. Freedman STATISTICAL SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More